Practice Test Geeks(MTM) Medication Therapy Management Certification for Pharmacists Practice Test
← All MTM Flashcard Decks

Behavioral Health Pharmacotherapy Flashcards

7 cards from real MTM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Behavioral Health Pharmacotherapy flashcards as text

  1. Which antiepileptic mood stabilizer requires monitoring for Stevens-Johnson syndrome, particularly in Asian patients carrying the HLA-B*1502 allele?

    Answer: Carbamazepine

    Carbamazepine is strongly associated with Stevens-Johnson syndrome in patients with the HLA-B*1502 allele, which is prevalent in Asian populations; genetic testing is recommended before use.

  2. An MTM pharmacist identifies that a patient with PTSD is taking prazosin. What is the primary indication for this medication in PTSD?

    Answer: Treating trauma-related nightmares and sleep disturbances

    Prazosin, an alpha-1 adrenergic blocker, reduces noradrenergic activity during sleep and is used off-label to reduce trauma-related nightmares and improve sleep quality in PTSD.

  3. A patient develops tardive dyskinesia after years of haloperidol use. Which medication is FDA-approved to treat this movement disorder?

    Answer: Valbenazine

    Valbenazine (Ingrezza) and deutetrabenazine are FDA-approved VMAT2 inhibitors indicated for the treatment of tardive dyskinesia.

  4. Which medication is considered first-line pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults?

    Answer: Amphetamine salts or methylphenidate

    Stimulant medications (amphetamines and methylphenidate) are first-line pharmacotherapy for adult ADHD due to superior efficacy compared to non-stimulant alternatives.

  5. A patient on lithium is started on ibuprofen for arthritis pain. What effect will this interaction have on lithium levels?

    Answer: Lithium levels will increase due to decreased renal clearance

    NSAIDs inhibit prostaglandin-mediated renal blood flow, reducing renal lithium clearance and increasing serum lithium levels, potentially causing toxicity.

  6. Which of the following is a key counseling point for patients initiating methadone maintenance therapy for opioid use disorder?

    Answer: Methadone requires daily observed dosing at a licensed opioid treatment program initially

    Federal regulations require that methadone for OUD be dispensed at DEA-licensed opioid treatment programs with observed daily dosing initially, with take-home doses earned through program compliance.

  7. A pharmacist reviews a patient's medication profile and finds clonazepam prescribed long-term for panic disorder. Per current guidelines, what counseling should be provided?

    Answer: Long-term use carries risks of dependence; gradual tapering and transition to SSRIs should be considered

    Guidelines recommend SSRIs/SNRIs as first-line maintenance therapy for panic disorder; long-term benzodiazepine use risks physical dependence, cognitive impairment, and abrupt discontinuation seizures.